107 related articles for article (PubMed ID: 2877663)
1. c-K-ras codon 12 GGT-CGT point mutation. An infrequent event in human lung cancer.
Milici A; Blick M; Murphy E; Gutterman JU
Biochem Biophys Res Commun; 1986 Oct; 140(2):699-705. PubMed ID: 2877663
[TBL] [Abstract][Full Text] [Related]
2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
3. A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer.
Deng GR
Nucleic Acids Res; 1988 Jul; 16(13):6231. PubMed ID: 2456524
[No Abstract] [Full Text] [Related]
4. Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.
Toyooka S; Tsukuda K; Ouchida M; Tanino M; Inaki Y; Kobayashi K; Yano M; Soh J; Kobatake T; Shimizu N; Shimizu K
Oncol Rep; 2003; 10(5):1455-9. PubMed ID: 12883723
[TBL] [Abstract][Full Text] [Related]
5. Activation of a human c-K-ras oncogene.
Yamamoto F; Perucho M
Nucleic Acids Res; 1984 Dec; 12(23):8873-85. PubMed ID: 6096811
[TBL] [Abstract][Full Text] [Related]
6. Biological properties of human c-Ha-ras1 genes mutated at codon 12.
Seeburg PH; Colby WW; Capon DJ; Goeddel DV; Levinson AD
Nature; 1984 Nov 1-7; 312(5989):71-5. PubMed ID: 6092966
[TBL] [Abstract][Full Text] [Related]
7. [Relation of c-Ha-ras point mutation to the prognosis and metastasis of gastric carcinoma].
Deng GR
Zhonghua Yi Xue Za Zhi; 1989 Aug; 69(8):438-42, 32. PubMed ID: 2575929
[TBL] [Abstract][Full Text] [Related]
8. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
9. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
Kumar R; Dunn LL
Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
[TBL] [Abstract][Full Text] [Related]
10. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.
Bizub D; Wood AW; Skalka AM
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6048-52. PubMed ID: 3016738
[TBL] [Abstract][Full Text] [Related]
11. A novel combination of K-ras and myc amplification accompanied by point mutational activation of K-ras in a human lung cancer.
Taya Y; Hosogai K; Hirohashi S; Shimosato Y; Tsuchiya R; Tsuchida N; Fushimi M; Sekiya T; Nishimura S
EMBO J; 1984 Dec; 3(12):2943-6. PubMed ID: 6098458
[TBL] [Abstract][Full Text] [Related]
12. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse.
Wiseman RW; Stowers SJ; Miller EC; Anderson MW; Miller JA
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5825-9. PubMed ID: 3016723
[TBL] [Abstract][Full Text] [Related]
13. Temporal changes in K-ras mutant fraction in lung tissue of big blue B6C3F₁ mice exposed to ethylene oxide.
Parsons BL; Manjanatha MG; Myers MB; McKim KL; Shelton SD; Wang Y; Gollapudi BB; Moore NP; Haber LT; Moore MM
Toxicol Sci; 2013 Nov; 136(1):26-38. PubMed ID: 24029818
[TBL] [Abstract][Full Text] [Related]
14. Amplifications of both c-Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes.
Yamada H; Sakamoto H; Taira M; Nishimura S; Shimosato Y; Terada M; Sugimura T
Jpn J Cancer Res; 1986 Apr; 77(4):370-5. PubMed ID: 3009377
[TBL] [Abstract][Full Text] [Related]
15. Studies on the relationship between the point mutation of ras oncogenes and the prognosis of patients with gastric cancer.
Fang DC; Luo YH; Lu R; Liu WW
World J Gastroenterol; 1997 Mar; 3(1):19-21. PubMed ID: 27006577
[TBL] [Abstract][Full Text] [Related]
16. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines.
Belinsky SA; Devereux TR; Maronpot RR; Stoner GD; Anderson MW
Cancer Res; 1989 Oct; 49(19):5305-11. PubMed ID: 2670201
[TBL] [Abstract][Full Text] [Related]
18. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
19. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
20. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
Needleman SW; Devine SE; Kraus MH
Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
